Print

Print


People have commented that theere seems to be a high number of  PWP who also have diabetes -- just an observation. A PD registry would  have helped prove or disprove. Or might it be age related?

An article in Nature mentions 2 diabetes drugs that might be tested for PD (although there are concerns about cardiac side effects.) A big question is ... are these available as generics yet ?. If not, who owns the patent and will they be willling to sponsor PD trials, -i.e. will they make enough money  to develop  an existing drug for trearting PD?

from Nature, Oct 2010 (published online

http://www.nature.com/news/2010/101006/full/news.2010.518.html

Damaged cell powerhouses linked to Parkinson's

"Such drugs have already been widely pursued as potential therapies for type 2 diabetes, and some have already been approved for that use. Avandia (rosiglitazone), a diabetes drug recently pulled from the European market because it raises the risk of heart attack, activates a key protein in the PGC-1α pathway.

But a related drug called Actos (pioglitazone) has not been firmly linked to heart attack and remains in use. Beal says that a clinical trial to test Actos in patients with Parkinson's disease has already been approved by regulators..."


www.pdpipeline.org

---------- Original Message ----------
From: Kathleen Cochran <[log in to unmask]>
To: [log in to unmask]
Subject: Re: another "breakthrough" PD power-switch located
Date: Thu, 7 Oct 2010 15:24:30 -0400

I wonder if there is any data regarding people with PD and diabetes who are
taking the drug they allude to.

Kathleen


On 6 October 2010 23:13, Rayilyn Brown <[log in to unmask]> wrote:

>
> http://www.thestar.com/article/871509--parkinson-s-disease-power-switch-located
>
> Ray
> Rayilyn Brown
> Past Director AZNPF
> Arizona Chapter National Parkinson Foundation
>
> ----------------------------------------------------------------------
> To sign-off Parkinsn send a message to: mailto:
> [log in to unmask]
> In the body of the message put: signoff parkinsn
>

----------------------------------------------------------------------
To sign-off Parkinsn send a message to: mailto:[log in to unmask]
In the body of the message put: signoff parkinsn

----------------------------------------------------------------------
To sign-off Parkinsn send a message to: mailto:[log in to unmask]
In the body of the message put: signoff parkinsn